Every Form 4 that DocuSign, Inc. (DOCU) has filed with the SEC in the last 12 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A Form 4 covers the transactions officers, directors and large holders report, so if you follow DOCU and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full DOCU filings page.
DOCUSIGN, INC. director Mary Agnes Wilderotter reported routine equity compensation and estate-planning moves. She received a grant of 4,384 restricted stock units (RSUs) on June 1, 2026, each representing one share of common stock, vesting in equal quarterly installments over one year subject to continued service.
On May 29, 2026, she exercised 729 RSUs into 729 shares of common stock, bringing her directly held common stock to 3,199 shares. Earlier, on April 2, 2026, she made a bona fide gift of 57,333 shares of common stock to the Wilderotter Family Trust for no consideration. She serves as trustee, and she and her immediate family are the sole beneficiaries, so she continues to be the beneficial owner of those trust-held shares.
DOCUSIGN director Peter Solvik reported equity compensation and a routine option-style exercise. On June 1, 2026, he received a grant of 4,384 Restricted Stock Units, each representing one share of common stock, vesting quarterly over one year starting on that date, subject to continued service.
On May 29, 2026, Solvik exercised 729 RSUs for 729 shares of common stock at an exercise price of $0.00, bringing his directly held common stock to 8,970 shares. The filing also lists indirect holdings, including 6,458 shares held by his spouse, 65,558 shares held by children’s trusts, 120,253 shares held by a trust, and 3 shares held by a family partnership. No open-market purchases or sales were reported.
DOCUSIGN, INC. director Cain A. Hayes reported routine equity compensation activity. On June 1, 2026, Hayes received a grant of 4,384 Restricted Stock Units (RSUs), each representing a right to one share of common stock, vesting quarterly over one year subject to continued service.
On May 29, 2026, Hayes exercised a prior RSU award, converting 729 RSUs into an equal number of common shares. Following these transactions, Hayes directly holds 15,717 shares of common stock and 4,384 RSUs, with no reported stock sales in this filing.
DocuSign director Irving Blake reported equity compensation activity. Blake received a grant of 4,384 restricted stock units (RSUs), each representing a contingent right to one share of DocuSign common stock. These RSUs have a vest commencement date of June 1, 2026 and will vest in equal quarterly installments over one year, with the final tranche vesting on the earlier of the next annual stockholder meeting or the one-year anniversary of the grant, subject to continued service.
On May 29, 2026, 729 RSUs were exercised and converted into 729 shares of common stock, reflecting a derivative exercise rather than an open-market purchase. Following this transaction, Blake directly held 26,093 shares of DocuSign common stock. The RSUs do not expire; they either vest or are canceled before vesting, so these transactions primarily reflect routine director compensation and vesting mechanics.
DocuSign director James A. Beer reported mixed equity activity, including a small open-market sale and routine equity awards. He sold 450 shares of common stock on June 2, 2026 at $55.04 per share in an open-market transaction under a pre-arranged Rule 10b5-1 plan, leaving him with 15,036 directly held shares. On May 29, 2026, 729 Restricted Stock Units (RSUs) converted into 729 shares of common stock as they vested. He also holds 5,543 shares indirectly through a trust. On June 1, 2026, he received a grant of 4,384 RSUs, each representing a right to one share of common stock, scheduled to vest in equal quarterly installments over one year, subject to continued service and the timing of the company’s next annual stockholder meeting.
DOCUSIGN, INC. director Anna Marrs reported a mix of equity compensation and routine trading activity. She sold 365 shares of common stock on June 2, 2026 at $55.04 per share under a pre-arranged Rule 10b5-1 trading plan, and held 12,615 common shares afterward.
On May 29, 2026, 729 Restricted Stock Units (RSUs) were exercised into 729 common shares, fully settling that RSU lot. On June 1, 2026, she received a grant of 4,384 RSUs, each representing one future share of common stock, vesting quarterly over one year based on continued service.
Trollope Rowan M reported acquisition or exercise transactions in this Form 4 filing.
DOCUSIGN, INC. director Rowan M. Trollope received a grant of 10,438 restricted stock units on May 8, 2026. Each RSU represents a contingent right to receive one share of DocuSign common stock.
The 10,438 RSUs will vest in twelve equal quarterly installments over three years, starting on May 2, 2026, as long as Trollope remains a service provider through each vesting date. The RSUs do not expire; they either vest into common shares or are canceled before vesting.
DOCUSIGN, INC. director Mary Agnes Wilderotter exercised stock options and sold shares in a routine transaction. She exercised options for 3,000 shares of Common Stock at an exercise price of $17.66 per share, then sold 3,000 shares at $48.15 per share on the same date.
After these transactions, she directly held 59,803 shares of DocuSign common stock. The derivative position tied to this specific option grant was fully exercised, with no remaining options from this grant shown in the filing.
DOCUSIGN, INC. Chief Revenue Officer Paula Hansen reported open-market sales of 6,000 shares of common stock on April 1, 2026. The transactions were executed under a pre-arranged Rule 10b5-1 trading plan, with sale prices ranging from about $45.85 to $48.00 per share. Following these sales, Hansen directly holds 79,233 shares of DocuSign common stock, indicating she retained a substantial equity position after the trades.
DOCUSIGN, INC. Chief Legal Officer James P. Shaughnessy reported selling a total of 12,000 shares of common stock in open-market transactions on April 1, 2026. The sales included 5,419 shares at $46.22, 6,481 shares at $47.33, and 100 shares at $48.00 per share. These transactions were executed under a pre-arranged Rule 10b5-1 plan, and following the sales he directly holds 53,631 shares of DocuSign common stock.
DOCUSIGN, INC. President and CEO Allan C. Thygesen sold 26,250 shares of Common Stock in three open-market transactions on April 1 pursuant to a pre-arranged Rule 10b5-1 plan. Sale prices ranged from about $45.89 to $48.38 per share, and he continues to hold 152,237 shares directly.
Roberts Brian Keith reported acquisition or exercise transactions in this Form 4 filing.
DocuSign director Brian Keith Roberts received a grant of 10,269 restricted stock units (RSUs). Each RSU represents the right to receive one share of DocuSign common stock. The award will vest in twelve equal quarterly installments over three years starting on March 5, 2026, as long as he remains a service provider. The RSUs have no traditional expiration date; they either vest on schedule or are canceled if vesting conditions are not met.
DocuSign, Inc. executive Robert Chatwani reported selling 16,696 shares of Common Stock in open-market transactions. The sales took place on March 18, 2026 at prices reported around $45.52 to $49.50 per share. After these trades, he directly holds 72,458 DocuSign shares. The filing notes the transactions were carried out under a pre-arranged Rule 10b5-1 trading plan, indicating they were scheduled in advance rather than timed discretionarily.
DOCUSIGN, INC. executive Robert Chatwani reported equity compensation activity, not open‑market trading. On March 15, 2026, he exercised and settled restricted stock units (RSUs) and performance stock units (PSUs) that convert into common stock on a one‑for‑one basis at an exercise price of $0.00 per share.
These settlements delivered 31,541 shares of common stock, while 12,584 shares were withheld by DocuSign to cover tax obligations tied to the vesting, as described in the footnotes. After these transactions, Chatwani directly owns 89,154 shares of DocuSign common stock. The RSUs and PSUs vest over multi‑year schedules and, for PSUs, depend on subscription revenue and free cash flow performance for specified fiscal periods.
Docusign, Inc. President and CEO Allan C. Thygesen reported multiple equity award vestings and conversions on March 15, 2026. He exercised restricted stock units and performance stock units into 65,560 shares of common stock. To cover tax obligations on these vestings, 29,334 shares were withheld by the company, a non-market disposition.
Following these transactions, Thygesen directly holds 178,487 shares of Docusign common stock. The RSUs vest in quarterly installments over four-year schedules starting on October 10, 2022, May 10, 2023, May 10, 2024, and May 10, 2025. The PSUs vest based on Docusign’s subscription revenue and free cash flow performance for the FY24 and FY25 performance periods, with potential vesting up to 200% of target if performance conditions are fully achieved.
DocuSign Chief Revenue Officer Paula Hansen reported equity compensation activity involving restricted and performance stock units. On March 15, 2026, she exercised or settled RSUs and PSUs into 32,515 shares of common stock, according to the filing.
The company withheld 16,252 shares of common stock to satisfy tax obligations tied to these vestings, a non-market disposition. Following these transactions, Hansen directly held 85,233 shares of common stock. The footnotes explain that RSUs and PSUs each convert into one share upon vesting and include multi‑year, performance-based vesting schedules.
DOCUSIGN, INC. Chief Legal Officer James P. Shaughnessy reported the vesting and settlement of equity awards into common stock. On March 15, 2026, he exercised restricted stock units and performance stock units that delivered 20966 shares of common stock. To cover tax obligations from these vestings, 9885 shares were withheld by the company, a non-market disposition. After these transactions, Shaughnessy directly holds 65631 shares of DocuSign common stock. The filing reflects routine equity compensation vesting rather than open-market buying or selling.
DocuSign, Inc.’s Chief Financial Officer Blake Jeffrey Grayson reported routine equity compensation activity. On 2026-03-15, he acquired 37,448 shares of common stock through the vesting and settlement of restricted stock units (RSUs) and performance stock units (PSUs).
To satisfy related tax obligations on these vestings, 15,365 shares of common stock were withheld by DocuSign, a non-market transaction classified as a tax-withholding disposition. After these transactions, Grayson directly owned 133,796 shares of DocuSign common stock.
DOCUSIGN, INC. director Anna Marrs reported a mix of stock-based transactions. On March 5, 2026, she completed an open-market sale of 363 shares of common stock at $46.33 per share, leaving her with 12,251 common shares held directly.
On March 4, 2026, she exercised 725 restricted stock units (RSUs), converting them into an equal number of common shares at $0.00 per share. Each RSU represents a right to receive one share of common stock and vests in twelve equal quarterly installments over three years starting on June 4, 2023, subject to continued service. The filing notes the sale was made under a pre-arranged Rule 10b5-1 trading plan.
DOCUSIGN, INC. director Enrique T. Salem reported an automatic conversion of equity awards rather than an open-market trade. On February 28, 2026, he exercised 729 Restricted Stock Units (RSUs), which converted into 729 shares of common stock at a price of $0.00 per share. After this conversion, his directly held common stock position rose to 166,589 shares.
Each RSU represents the right to receive one share of common stock. The underlying RSU grant has a vest commencement date of May 29, 2025 and vests in equal quarterly installments over one year, with the final installment vesting on the earlier of the next annual stockholder meeting or the one-year anniversary of the grant, subject to continued service. The RSUs themselves do not expire.
DocuSign director Teresa Briggs reported the conversion of restricted stock units into common shares. On the reported date, 729 Restricted Stock Units were exercised at a stated price of $0.0000 per unit, resulting in 729 shares of common stock. After this derivative exercise and corresponding acquisition, she directly owned 9,899 shares of DocuSign common stock. Each RSU represents a right to receive one share and, per the disclosure, RSUs vest in equal quarterly installments over one year from a vest commencement date of May 29, 2025, provided she remains a service provider through each vesting date.
DocuSign, Inc. director Irving Blake reported acquiring shares through an equity award. On February 28, 2026, 729 Restricted Stock Units were exercised or converted into 729 shares of common stock at a stated price of $0.00 per share, bringing his direct common stock holdings to 25,364 shares.
Each RSU represents a right to receive one share of common stock. The RSUs have a vest commencement date of May 29, 2025 and vest in equal quarterly installments over one year, subject to continued service. The RSUs do not expire and will either vest or be canceled before the vesting date.
DocuSign director Peter Solvik reported an equity award transaction involving restricted stock units. On February 28, 2026, he exercised 729 Restricted Stock Units, which converted into 729 shares of DocuSign common stock at a stated price of $0.00 per share.
After this conversion, Solvik directly held 8,241 shares of common stock. The filing also notes indirect holdings as of that date, including 120,253 shares by a trust, 65,558 shares by children's trusts, 3 shares by a family partnership, and 6,458 shares by his spouse. Each RSU represents a right to receive one share and vests in quarterly installments over one year starting May 29, 2025.
DOCUSIGN, INC. director Mary Agnes Wilderotter acquired 729 shares of common stock through the exercise and conversion of Restricted Stock Units on February 28, 2026 at a price of $0.00 per share. Following this transaction, she directly holds 59,803 common shares.
Each RSU represents a right to receive one share of common stock. These RSUs have a vest commencement date of May 29, 2025 and vest in equal quarterly installments over one year, with the final installment vesting on the earlier of the next annual stockholder meeting or the one-year anniversary of the grant, subject to her continued service. The RSUs do not expire; they either vest or are canceled before vesting.
DocuSign director James A. Beer reported mixed insider activity. On March 3, 2026, he sold 450 shares of common stock in an open-market trade at $45.02 per share under a pre-arranged Rule 10b5-1 plan. On February 28, 2026, he acquired 729 shares of common stock from the conversion of 729 Restricted Stock Units. Following these transactions, he directly held 14,757 common shares, with an additional 5,543 shares held indirectly by a trust.
DOCUSIGN, INC. director Cain A. Hayes reported an equity award conversion rather than an open-market trade. On February 28, 2026, 729 Restricted Stock Units were exercised at $0.00 per unit, delivering 729 shares of common stock.
Following this transaction, Hayes directly owned 14,988 shares of DocuSign common stock. A separate line shows 729 Restricted Stock Units remaining directly held, each representing a contingent right to receive one share of common stock, subject to the disclosed vesting conditions.
DOCUSIGN, INC. director Michael George Rosenbaum reported the exercise or conversion of restricted stock units into common stock. On March 3, 2026, he exercised 522 restricted stock units at a price of $0.0000 per unit, receiving 522 shares of common stock. After these transactions, he directly held 5,221 restricted stock units and 1,044 shares of common stock. Each RSU represents the right to receive one share of common stock and will vest in twelve equal quarterly installments over three years starting on September 3, 2025, as long as he continues as a service provider.
DOCUSIGN, INC. director Anna Marrs reported mixed share activity. On March 3, 2026, she executed an open-market sale of 365 shares of common stock at $45.02 per share under a pre-arranged Rule 10b5-1 plan, leaving 11,889 shares of common stock directly owned.
On February 28, 2026, 729 Restricted Stock Units (RSUs) were exercised into 729 shares of common stock. Each RSU represents one share, with RSUs scheduled to vest quarterly starting May 29, 2025 over one year, subject to continued service, and they either vest or are canceled rather than expiring.
DocuSign, Inc. director Teresa Briggs reported an open-market sale of common stock. On February 27, 2026, she sold 364 shares at an average price of $44.31 per share under a pre-arranged Rule 10b5-1 trading plan. Following this planned sale, she directly owns 9,170 shares of DocuSign common stock.
DocuSign, Inc. Chief Financial Officer Blake Jeffrey Grayson reported selling 6,500 shares of the company’s common stock on January 9, 2026 at a price of $70 per share. The filing states that the transaction was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person, indicating it was pre-arranged rather than a discretionary trade. After this sale, Grayson directly held 111,713 shares of DocuSign common stock.
DocuSign, Inc. President and CEO Allan C. Thygesen reported planned sales of company common stock. On January 9, 2026, he completed three open-market sales under a Rule 10b5-1 trading plan. The reported transactions were sales of 16,151 shares at $69.35, 9,799 shares at $69.98, and 300 shares at $70.83 per share. Footnotes note that the shares in each trade were sold within stated price ranges and that full price breakdowns are available on request. Following these sales, Thygesen directly beneficially owned 142,261 shares of DocuSign common stock.
DocuSign, Inc. Chief Revenue Officer Paula Hansen reported multiple open-market sales of company common stock. On January 2, 2026, she sold a total of 6,000 shares of DocuSign common stock in four separate transactions, at reported prices of $65.43, $66.94, $67.78, and $68.62 per share.
The filing states that these sales were made under a pre-arranged Rule 10b5-1 trading plan adopted by Hansen, which is designed to allow insiders to sell shares according to a preset schedule. Following the reported sales, Hansen directly beneficially owned 68,970 shares of DocuSign common stock.
Docusign, Inc. reported that its Chief Legal Officer, James P. Shaughnessy, sold common stock in multiple transactions on 01/02/2026. He sold a total of 12,000 shares of Docusign common stock in four separate sales, at prices generally between $64.97 and $68.68, as reflected by the detailed price ranges in the footnotes. These sales were executed pursuant to a Rule 10b5-1 trading plan previously adopted by Shaughnessy. Following the reported transactions, he beneficially owned 54,550 shares of Docusign common stock directly.
DocuSign, Inc. director reported an insider transaction involving company common stock. On 12/10/2025, the reporting person made a transaction coded "G" (a gift) of 15,000 shares of common stock at a stated price of $0, held indirectly through a trust.
After this transaction, the reporting person beneficially owned 120,253 shares of DocuSign common stock indirectly through a trust, in addition to 7,512 shares held directly, 65,558 shares held indirectly by children's trusts, 6,458 shares held indirectly by a spouse, and 3 shares held indirectly through a family partnership.
DocuSign, Inc. Chief Financial Officer, identified as an officer of the company, reported multiple equity transactions in December 2025. On 12/15/2025, the CFO acquired 37,453 shares of common stock at $0 through the vesting and settlement of restricted stock units (RSUs) and performance stock units (PSUs), and 15,385 shares were withheld to cover tax obligations. Following these transactions, the CFO directly held 127,728 shares of common stock.
On 12/17/2025, the CFO sold 3,525 shares at an average price within a range of $67.31 to $68.29, and 5,990 shares at prices ranging from $68.33 to $69.05, under a pre-established Rule 10b5-1 trading plan. The filing also details ongoing RSU and PSU awards that vest over several years or based on DocuSign’s FY25 subscription revenue and free cash flow performance.
DocuSign's chief legal officer reported multiple stock-based compensation events on December 15, 2025. Several batches of restricted stock units (RSUs) and performance stock units (PSUs) converted into common stock at an exercise price of $0, adding 20,968 shares of common stock.
To cover taxes on these vestings, 9,860 shares were withheld by the company, reducing the net increase in directly held stock. After the reported transactions, the officer directly owned 66,550 shares of DocuSign common stock. The filing also details remaining RSU and PSU awards that continue to vest over time based on service and performance conditions tied to subscription revenue and free cash flow for specified performance periods.
DocuSign, Inc.’s Chief Revenue Officer reported equity award activity involving company stock. On 12/15/2025, the executive acquired 32,515 shares of DocuSign common stock at $0 following the vesting and settlement of restricted stock units (RSUs) and performance stock units (PSUs). To cover tax obligations triggered by this vesting, 16,513 shares were withheld by the company, also at $0 per share. After these transactions, the officer directly beneficially owned 74,970 shares of common stock. The filing also shows continuing holdings of RSUs and PSUs that may convert into additional shares over time, subject to time-based vesting, performance targets tied to subscription revenue and free cash flow for the FY25 performance period, and continued service conditions.
DocuSign, Inc. reported insider stock activity by its President and General Manager, Growth. On December 15, 2025, the executive sold 1,683 shares of common stock at $70.87 per share under a Rule 10b5-1 trading plan. That same day, vested equity awards were exercised, adding 31,538 shares, and the company withheld 16,019 shares at no price to cover tax obligations from vesting restricted and performance stock units.
On December 17, 2025, the executive completed additional open-market sales of 5,253 shares at an average price of $67.88 and 8,565 shares at an average price of $68.61, with exact prices ranging from $67.31 to $69.05. Following these transactions, the executive directly held 70,197 shares of DocuSign common stock, along with multiple tranches of restricted stock units and performance stock units that may convert into shares over time based on service and performance conditions.
DocuSign, Inc. President and CEO, who also serves as a director, reported equity award activity dated 12/15/2025. The filing shows the exercise and settlement of restricted stock units into 65,561 shares of common stock, with 33,296 shares withheld to cover tax obligations, leaving 168,511 shares of common stock held directly after the transactions.
Multiple grants of restricted stock units and performance stock units remain outstanding, each convertible into common stock at an exercise price of $0. These awards vest over multi‑year schedules, generally in quarterly installments, conditioned on continued service and, for performance stock units, on achieving subscription revenue and free cash flow targets for the FY24 and FY25 performance periods, with potential vesting capped at 200% of target.
DocuSign, Inc. reported that one of its officers, listed as President General Mgr, Growth, sold 983 shares of common stock on 12/11/2025.
The sale was executed at a price of $68.62 per share under a pre-arranged Rule 10b5-1 trading plan adopted by the reporting person, and was coded as a sale transaction. After this trade, the officer beneficially owns 70,179 shares of DocuSign common stock, held directly.